51142419 Dotarizine

Definition

UNSPSC 51142419

This classification denotes a serotonin antagonist and calcium channel blocker with the molecular formula C29H34N2O2, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier IO7663S6D3, chemically known as 1-(diphenylmethyl)-4-(3-(2-phenyl-1,3-dioxolan-2-yl)propyl)piperazine but generally known as dotarizine, which bears US NIH Compound Identifier 55285. European Medicines Agency schedules Dotarizine in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB06378MIG. The term DOTARIZINE is an International Non-Proprietary Name or INN (see WHO INN reference publication, Volume 38, No. 6, 1984, List 24). DOTARIZINE is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix. Most nations schedule dotarizine under HS 29349990 and SITC 51579. As of Q4 2014, DOTARIZINE remains the US FDA Preferred Term for this commodity. Dotarizine bears US NLM identifiers UMLS ID C0248284 and NCI Concept Code C77827. SMILES: O1C(OCC1)(CCCN1CCN(CC1)C(C1CCCCC1)C1CCCCC1)C1CCCCC1.

Same parent

Under 51142400 · 29

51142401 Methysergide Commodity 51142404 Dihydroergotamine Commodity 51142405 Combination acetaminophen acetylsalicylic acid Commodity 51142408 Frovatriptan Commodity 51142411 Rizatriptan Commodity 51142412 Eletriptan Commodity 51142413 Zolmitriptan Commodity 51142414 Sumatriptan Commodity 51142415 Combination acetaminophen butalbital Commodity 51142416 Iprazochrome Commodity 51142417 Almotriptan Commodity 51142418 Donitriptan Commodity 51142419 Dotarizine You are here 51142420 Ergotamine Commodity 51142421 Naratriptan Commodity 51142422 Oxetorone Commodity 51142423 Almotriptan malate Commodity 51142424 Dihydroergotamine mesilate or mesylate Commodity 51142425 Dihydroergotamine methanesulfonate Commodity 51142426 Donitriptan hydrochloride Commodity 51142427 Eletriptan hydrobromide Commodity 51142428 Ergotamine tartrate Commodity 51142429 Frovatriptan succinate Commodity 51142430 Frovatriptan succinate hydrate Commodity 51142431 Methysergide maleate Commodity 51142432 Naratriptan hydrochloride Commodity 51142433 Rizatriptan benzoate Commodity 51142434 Rizatriptan sulfate Commodity 51142435 Sumatriptan succinate Commodity

Activities that produce or sell this

KBLI · 8

Inherited from family 51140000.

21012 Industri Produk Farmasi untuk Manusia Sub-class 21013 Industri Produk Farmasi untuk Hewan Sub-class 46441 Perdagangan Besar Sediaan Farmasi untuk Manusia Sub-class 46442 Perdagangan Besar Sediaan Farmasi untuk Hewan Sub-class 46902 Perdagangan Besar Berbagai Macam Barang Selain di Grosir/Perkulakan Swalayan Sub-class 47721 Perdagangan Eceran Sediaan Farmasi untuk Manusia di Apotek Sub-class 47722 Perdagangan Eceran Sediaan Farmasi untuk Manusia Selain di Apotek Sub-class 47726 Perdagangan Eceran Obat Farmasi untuk Hewan Sub-class